APA (7th ed.) Citation

K, S., A, A., N, M., E, B., N, T., M, I., . . . C, E. (2021). Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neck. European journal of cancer (Oxford, England : 1990), 157, 190. https://doi.org/10.1016/j.ejca.2021.08.030

Chicago Style (17th ed.) Citation

K, Saleh, et al. "Efficacy and Safety of Immune Checkpoint Inhibitors in Elderly Patients (≥70 Years) with Squamous Cell Carcinoma of the Head and Neck." European Journal of Cancer (Oxford, England : 1990) 157 (2021): 190. https://doi.org/10.1016/j.ejca.2021.08.030.

MLA (9th ed.) Citation

K, Saleh, et al. "Efficacy and Safety of Immune Checkpoint Inhibitors in Elderly Patients (≥70 Years) with Squamous Cell Carcinoma of the Head and Neck." European Journal of Cancer (Oxford, England : 1990), vol. 157, 2021, p. 190, https://doi.org/10.1016/j.ejca.2021.08.030.